Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05730309 · ClinicalTrials.gov registry record · NA
Point-of-care Ultrasound and Treatment Disparities for Left Ventricular Hypertrophy
A NA study of Left Ventricular Hypertrophy, sponsored by Yale University.
- Recruiting
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT05730309: Recruiting NA study of Left Ventricular Hypertrophy, sponsored by Yale University.
NCT05730309 is a NA study of Left Ventricular Hypertrophy that is actively recruiting participants, run by Yale University. The registered enrollment target is 200 participants, roughly in line with the 189-participant average among 7 other Left Ventricular Hypertrophy trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05730309, a NA study of Left Ventricular Hypertrophy, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of the proposed project is to quantify the prevalence and disparities of undiagnosed left ventricular hypertrophy (LVH) in Emergency Department (ED) patients with persistently elevated asymptomatic BP, and to measure the effect of disclosure, education, and expedited referral on 3-month outpatient follow-up and treatment rates for ED patients with newly diagnosed LVH by POCUS. Additionally, investigators will create a database of annotated clips for future development of a machine learning algorithm for LVH detection on POCUS.
Primary Outcome
LVH point prevalence will be determined based on ultrasound measurements of left ventricular wall thickness and/or left ventricular mass, expressed as percentage of total population enrolled in the study.
Conditions Studied
Interventions
- BEHAVIORAL Customized discharge and expedited referral instructions
Study Locations (1)
Connecticut
- Yale New Haven Hospital - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-10-15 |
| Est. Completion | 2025-12 |
| Phase | NA |
What NCT05730309 shows while recruiting
NCT05730309 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 189-participant average among 7 other Left Ventricular Hypertrophy trials with a reported enrollment target.
The record links to 1 condition, with Left Ventricular Hypertrophy appearing as the primary indexed condition, and to 1 intervention - of which Customized discharge and expedited referral instructions is the first listed.
NCT05730309 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT05730309 about?
NCT05730309 is a clinical study titled "Point-of-care Ultrasound and Treatment Disparities for Left Ventricular Hypertrophy". The objective of the proposed project is to quantify the prevalence and disparities of undiagnosed left ventricular hypertrophy (LVH) in Emergency Department (ED) patients with persistently elevated asymptomatic BP, and to measure the effect of disclosure, education, and expedited referral on 3-mont...
What is the current status of trial NCT05730309?
This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2023-10-15. Estimated completion is 2025-12.
What conditions does trial NCT05730309 study?
This clinical trial studies the following conditions: Left Ventricular Hypertrophy.
What interventions are being tested in trial NCT05730309?
The interventions under investigation include: Customized discharge and expedited referral instructions (BEHAVIORAL).
Who is sponsoring clinical trial NCT05730309?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05730309 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Left Ventricular Hypertrophy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Imaging Histone Deacetylase in the Heart
RECRUITING · NA
-
Sodium Lowering Vascular Effects Trial
RECRUITING · NA
-
US Benchmarking Clinical Study
RECRUITING
-
Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)
RECRUITING
-
Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension
RECRUITING · Phase 4
-
Diffusion MRI in Heart Failure
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI